Middle East & Africa Pharmaceutical Market Size & Outlook
Middle East & Africa pharmaceutical market, 2018-2030 (US$M)
Related Markets
MEA pharmaceutical market highlights
- The MEA pharmaceutical market generated a revenue of USD 60,596.7 million in 2024.
- The market is expected to grow at a CAGR of 5.1% from 2025 to 2030.
- In terms of segment, conventional drugs (small molecules) was the largest revenue generating molecule in 2024.
- Biologics & Biosimilars (Large Molecules) is the most lucrative molecule segment registering the fastest growth during the forecast period.
- Country-wise, UAE is expected to register the highest CAGR from 2025 to 2030.
MEA data book summary
| Market revenue in 2024 | USD 60,596.7 million |
| Market revenue in 2030 | USD 81,559.9 million |
| Growth rate | 5.1% (CAGR from 2025 to 2030) |
| Largest segment | Conventional drugs (small molecules) |
| Fastest growing segment | Biologics & Biosimilars (Large Molecules) |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biologics & Biosimilars (Large Molecules), Conventional Drugs (Small Molecules) |
| Key market players worldwide | Merck & Co Inc, Roche Holding AG, Novartis AG ADR, AbbVie Inc, Johnson & Johnson, Pfizer Inc, Bristol-Myers Squibb Co, Sanofi SA, GSK PLC, Takeda Pharmaceutical Co Ltd |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.7% of the global pharmaceutical market in 2024.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 503,932.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical Market Scope
Pharmaceutical Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Middle East & Africa pharmaceutical market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pharmaceutical market will help companies and investors design strategic landscapes.
Conventional drugs (small molecules) was the largest segment with a revenue share of 57.01% in 2024. Horizon Databook has segmented the Middle East & Africa pharmaceutical market based on biologics & biosimilars (large molecules), conventional drugs (small molecules) covering the revenue growth of each sub-segment from 2018 to 2030.
The Middle East and Africa (MEA) region is rapidly emerging as a vital pharmaceutical market, offering significant untapped opportunities for investors, particularly in the pharmaceutical and medical sectors. The region’s strategic position between global markets, coupled with ongoing economic reforms and growing infrastructure, is transforming it into a key hub for global supply chains.
For Middle Eastern businesses, the MEA market offers not only a growing consumer base but also a cost-efficient platform for production, distribution, and access to new markets. Africa’s geographic location offers a key logistical advantage by bridging critical trade routes between Asia, Europe, and the Americas.
This positioning gives Middle Eastern pharmaceutical companies a significant edge when it comes to logistics. Agreements like the African Continental Free Trade Area (AfCFTA)—connecting 1.4 billion people and a GDP of USD 3.4 trillion—are boosting intra-continental trade and fostering new export opportunities for Middle Eastern companies in the pharmaceutical sector.
Reasons to subscribe to Middle East & Africa pharmaceutical market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Middle East & Africa pharmaceutical market databook
-
Our clientele includes a mix of pharmaceutical market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Middle East & Africa pharmaceutical market , including forecasts for subscribers. This continent databook contains high-level insights into Middle East & Africa pharmaceutical market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
MEA pharmaceutical market size, by country, 2018-2030 (US$M)
Middle East & Africa Pharmaceutical Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
No records
No related industry reports found.
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
